Vertebral osteomyelitis in an immunosuppressed patient with rheumatoid arthritis U Giri, BC Thavalathil, R Varghese Case Reports 2014, bcr2014206944, 2014 | 11 | 2014 |
Survival outcomes in the very elderly with DLBCL prior to and after the introduction of rituximab: a US population-based study U Giri, MG Martin Blood advances 1 (10), 615-618, 2017 | 10 | 2017 |
Impact of margin status on survival after radical nephrectomy for renal cell carcinoma LK Morris, A Altahan, J Gandhi, J Mays, U Giri, M Fleming, MG Martin Journal of Surgical Oncology 123 (2), 687-692, 2021 | 5 | 2021 |
Second Primary Malignancies and Cardiovascular Mortality in Hodgkin Disease (HD) Survivors–A SEER Database Study U Giri, K Patel, M Martin International Journal of Radiation Oncology, Biology, Physics 102 (3), e746, 2018 | 1 | 2018 |
Survival Outcomes in Grade 3 Follicular Lymphoma Prior to and after the Introduction of Rituximab-an Analysis Based on the Surveillance, Epidemiology, and End Result Registry … U Giri, MG Martin Blood, The Journal of the American Society of Hematology 128 (22), 2967-2967, 2016 | 1 | 2016 |
Extramedullary Hematopoiesis in SCD Is More Prevalent Than Previously Recognized S Alan, N Bade, U Giri, R Fusisi, SM Marti, C Zik, WB Ershler Journal of Sickle Cell Disease 1 (Supplement_1), 2024 | | 2024 |
Ineffective Erythropoiesis with Aging in Adults with Sickle Cell Disease U Giri, A Sheinei, C Zik, R Fusisi, WB Ershler Blood 142, 2505, 2023 | | 2023 |
Characteristics and Outcomes for Adult Patients with T-Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL): A Retrospective Study JH McLain, M Macdonald, M Juarez, H Tun, U Giri, ME Vergara-Lluri, ... Blood 140 (Supplement 1), 11588-11589, 2022 | | 2022 |
Time to Diagnosis and Treatment in an Underserved, Predominantly Hispanic Population of Adults in East Los Angeles-a Retrospective Study of Acute T-Lymphoblastic Leukemia … M Macdonald, M Juarez, JH McLain, ME Vergara-Lluri, I Siddiqi, U Giri, ... Blood 140 (Supplement 1), 11598-11599, 2022 | | 2022 |
Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center. NA Bade, U Giri, H Wang, WB Ershler Transfusion 62 (7), 1462-1464, 2022 | | 2022 |
Venous thromboembolism in patients on check point inhibitors. U Giri, X Yu, K Resnick, T Larsen, GK In Journal of Clinical Oncology 39 (15_suppl), e14582-e14582, 2021 | | 2021 |
Molecular evaluation of immunogenicity and genomic alterations in invasive lobular breast cancer U Giri, T Karadimitriou, J Xiu, S Castanon, F Acequia, P Pohlmann, ... bone 11 (2), 13, 2021 | | 2021 |
Second Primary Malignancies and Cardiovascular Mortality in Hodgkin disease Survivors—a Surveillance, Epidemiology, and End Results Registry Database Study U Giri, K Patel, MG Martin Blood 130, 1513, 2017 | | 2017 |
Survival outcomes for various treatment modalities in early-stage grade 3 follicular lymphoma (FL3): a National Cancer Database (NCDB) study. U Giri, E Vick, SSH Lee, A Altahan, NA VanderWalde, PV Dickson, ... Journal of Clinical Oncology 35 (15_suppl), 7551-7551, 2017 | | 2017 |
Effect of adding immunotherapy (IT) to treatment regimen of mantle cell lymphoma (MCL): Analysis of the National Cancer Data Base (NCDB). A Altahan, E Vick, U Giri, E Wiedower, MG Martin Journal of Clinical Oncology 35 (15_suppl), e19022-e19022, 2017 | | 2017 |
Impact of margin status on survival after radical nephrectomy for renal cell carcinoma (RCC). LK Morris, A Altahan, J Mays, U Giri, E Wiedower, DA Vaena, MD Fleming, ... Journal of Clinical Oncology 35 (15_suppl), e16084-e16084, 2017 | | 2017 |
Survival outcomes for various treatment modalities in advanced-stage grade 3 follicular lymphoma (FL3): A National Cancer Database (NCDB) study. U Giri, E Vick, SSH Lee, A Altahan, NA VanderWalde, PV Dickson, ... Journal of Clinical Oncology 35 (15_suppl), 7554-7554, 2017 | | 2017 |